Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity.

British Journal of Pharmacology
Jean Jerley N SilvaJoão S Silva

Abstract

The discovery of the pharmacological functions of nitric oxide has led to the development of NO donor compounds as therapeutic agents. A new generation of ruthenium NO donors, cis-[Ru(NO)(bpy)(2)L]X(n), has been developed, and our aim was to show that these complexes are able to lyse Trypanosoma cruzi in vitro and in vivo. NO donors were incubated with T. cruzi and their anti-T. cruzi activities evaluated as the percentage of lysed parasites compared to the negative control. In vivo, trypanocidal activity was evaluated by observing the levels of parasitaemia, survival rate and elimination of amastigotes in mouse myocardial tissue. The inhibition of GAPDH was monitored by the biochemical reduction of NAD(+) to NADH. The NO donors cis-[Ru(NO)(bpy)(2)L]X(n) presented inhibitory effects on T. cruzi GAPDH (IC(50) ranging from 89 to 153 microM). The crystal structure of the enzyme shows that the inhibitory mechanism is compatible with S-nitrosylation of the active cysteine (cys166) site. Compounds cis-[Ru(NO)(bpy)(2)imN](PF(6))(3) and cis-[Ru(NO)(bpy)(2)SO(3)]PF(6), at a dose of 385 nmol.kg(-1), yielded survival rates of 80 and 60%, respectively, in infected mice, and eradicated any amastigotes from their myocardial tissue. The ruthe...Continue Reading

References

Apr 1, 1985·British Medical Bulletin·F R Opperdoes
Feb 1, 1985·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·R D Bruce
Jan 1, 1995·Acta Crystallographica. Section A, Foundations of Crystallography·R H Blessing
Aug 1, 1997·Acta Tropica·S C BourguignonS Giovanni-De-Simone
Dec 16, 1998·Archives of Biochemistry and Biophysics·J M Souza, R Radi
Oct 24, 2001·Inorganic Chemistry·Simone da S. S. BorgesDouglas W. Franco
Jul 25, 2003·Frontiers in Bioscience : a Journal and Virtual Library·Joao S SilvaGislaine A Martins
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Douglas T HessJonathan S Stamler
May 18, 2005·Regulatory Toxicology and Pharmacology : RTP·Eva SchledeDetlev Kayser
Jun 21, 2005·Inorganic Chemistry·Federico Roncaroli, José A Olabe
Feb 28, 2006·European Journal of Medicinal Chemistry·Raphael S F SilvaSolange L de Castro
Apr 22, 2006·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Juan Diego MayaAntonio Morello
Jun 27, 2006·Trends in Parasitology·Dirk Engels, Lorenzo Savioli
Aug 30, 2006·Human & Experimental Toxicology·José A CastroLaura C Bartel
Dec 26, 2006·Scientific American·Jeffrey D Sachs
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Apr 12, 2007·Memórias do Instituto Oswaldo Cruz·Paulo M M GuedesLúcia M C Galvão
Jul 3, 2007·British Journal of Pharmacology·J J N SilvaD W Franco
Aug 7, 2007·Archives of Biochemistry and Biophysics·Brenda E LopezJon M Fukuto
Oct 24, 2007·JAMA : the Journal of the American Medical Association·Madhuri ReddyPaula A Rochon
Feb 29, 2008·Journal of Chemical Information and Modeling·Rafael V C GuidoAdriano D Andricopulo
Jun 24, 2008·Journal of Medicinal Chemistry·Jean Jerley Nogueira SilvaDouglas Wagner Franco
Sep 16, 2008·Bioorganic & Medicinal Chemistry·Junia M PereiraArlene G Corrêa
Jul 8, 2009·Antimicrobial Agents and Chemotherapy·Jean Jerley N SilvaDouglas W Franco

❮ Previous
Next ❯

Citations

Oct 5, 2010·Current Opinion in Infectious Diseases·Frederick S Buckner, Nazlee Navabi
Jul 8, 2011·Clinical Microbiology Reviews·Antonio R L TeixeiraNadjar Nitz
Dec 21, 2013·The Journal of Venomous Animals and Toxins Including Tropical Diseases·Paulo Câmara Marques Pereira, Elaine Cristina Navarro
Dec 14, 2011·Neurochemical Research·Marcio Wilker Soares CampeloPaulo Roberto Leitão de Vasconcelos
May 27, 2014·Expert Opinion on Investigational Drugs·Maria Terezinha BahiaVanessa Carla Furtado Mosqueira
Dec 20, 2011·Nitric Oxide : Biology and Chemistry·Elia TfouniDouglas Wagner Franco
Dec 31, 2015·Infectious Diseases of Poverty·Qin Liu, Xiao-Nong Zhou
May 19, 2016·ACS Chemical Biology·Eduardo Henrique Silva SousaPeter J Sadler
Oct 3, 2014·PLoS Neglected Tropical Diseases·Renata Sesti-CostaJoão S Silva
Nov 1, 2016·Mediators of Inflammation·Tatiane Marcusso OrsiniWander Rogério Pavanelli
May 11, 2016·Revista Da Sociedade Brasileira De Medicina Tropical·Natália Yoshie KawakamiWander Rogério Pavanelli
Oct 14, 2011·Acta Cirúrgica Brasileira·Marcio Wilker Soares CampeloPaulo Roberto Leitão de Vasconcelos
Feb 6, 2017·Dalton Transactions : an International Journal of Inorganic Chemistry·P I da S MaiaU Abram
Nov 29, 2016·Journal of Inorganic Biochemistry·Eduardo Henrique Silva SousaMarie-Alda Gilles-Gonzalez
Jul 1, 2017·Expert Opinion on Drug Discovery·Ricardo A M SerafimElizabeth I Ferreira
Sep 24, 2014·Journal of Biomolecular Screening·Eric Chatelain
Aug 11, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Camila Fontes Neves da SilvaSofia Nikolaou
Mar 17, 2020·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Aurideia P de SousaAlda K M Holanda
Apr 29, 2010·British Journal of Pharmacology·Fabiana S MachadoMauro M Teixeira
Sep 28, 2018·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·M Florencia MosquilloLeticia Pérez-Díaz
Feb 6, 2020·Acta Cirúrgica Brasileira·Clóvis Ney Pinheiro MacêdoMarcio Wilker Soares Campelo
Mar 28, 2019·Frontiers in Pharmacology·Ana C RossaneisWaldiceu A Verri
Mar 13, 2021·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Pollyana Maria de Oliveira PimentelFabiana Simão Machado
Apr 10, 2021·Journal of Experimental Pharmacology·Ana Lia MazzetiVanessa Carla Furtado Mosqueira
Jul 3, 2021·Pharmaceutics·Alexandra-Cristina Munteanu, Valentina Uivarosi
Jul 30, 2019·Diagnostic Microbiology and Infectious Disease·Ramon R P P B de MenezesAlice M C Martins
Dec 7, 2018·Chemical Reviews·Yih Ching OngGilles Gasser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.